Rapport Therapeutics Inc. trailing returns
How Rapport Therapeutics Inc. (RAPP) has performed over the last day, week, month and year and since inception, through October 20, 2026 — price return and dividends side by side, with the worst drop inside each window.
Trailing returns by period#
To 2026-10-20. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.
| Period | Price | DivsDividends | Total | Worst drop |
|---|---|---|---|---|
| 1 day | +2.7% | +0.0% | +2.7% | — |
| 5 days | +1.3% | +0.0% | +1.3% | -6.8%Oct 16 |
| 1 month | -27.4% | +0.0% | -27.4% | -33.5%Oct 16 |
| YTD | -3.2% | +0.0% | -3.2% | -47.5%Oct 16 |
| 1 year | +11.1% | +0.0% | +11.1% | -47.5%Oct 2026 |
| Since inception (2024) | +15.7% | +0.0% | +15.7%+41.2% | -75.5%Mar 2025 |
Growth of RAPP#
Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.
- Since inception (2024)+15.7%/year · +41.2%
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-20). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in RAPP's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Rapport Therapeutics Inc.'s return since inception?
- Since 2024, Rapport Therapeutics Inc. (RAPP) has compounded at about +15.7% a year — +41.2% in total.